ArticleOpen medicine (Warsaw, Poland)2022

Inhibition of miR-21 improves pulmonary vascular responses in bronchopulmonary dysplasia by targeting the DDAH1/ADMA/NO pathway.

Ying Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.